Egnite touts AI algorithm at TCT 2021

The company’s Disease Progression algorithm was designed to predict the likelihood a patient with moderate aortic stenosis would later be diagnosed with severe stenosis over a one- and two-year period. The software can help physicians identify and prioritize the review of patients with moderate aortic stenosis who are at higher risk of progressing to severe disease, the company said.

Researchers analyzed 719,321 echo exams and found the algorithm was able to successfully predict progression rates for patients with an average error rate of 3.1%.

The algorithm is part of egnite’s…